The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines

This publication has 121 references indexed in Scilit:

• Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
  Cancer Immunology, Immunotherapy, 2013
• The Pancreas Cancer Microenvironment
  Clinical Cancer Research, 2012
• Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
  Nucleic Acids Research, 2011
• A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma
  Annals of Surgery, 2011
• Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
  Cancer Research, 2010
• Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA
  Cell Stem Cell, 2010
• Cellular Vaccine Approaches
  The Cancer Journal, 2010
• Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
  Journal of Clinical Oncology, 2009
• Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
  Molecular Therapy, 2008
• Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study
  British Journal of Cancer, 2006